Salivary gland cancers (SGCs) are rare, accounting for less than 5% of all malignancies of
the head and neck region, and are morphologically heterogeneous. The diagnosis is mainly …

Abstract Salivary Gland carcinomas (SGCs) are rare tumors accounting for less than 1% of
all cancers with 21 histologically diverse subtypes. The rarity of the disease presents a …

Background Immunotherapies targeting immune checkpoints have gained increasing
attention in cancer treatment, emphasizing the need for predictive biomarkers. Circular …

Background Treatment of salivary gland tumors (SGTs) remains challenging. Little is known
about the immune landscape of SGTs. We aimed to characterize the tumor …

Simple Summary The efficacy of immunotherapies in salivary gland cancer (SGC) remains
controversial. To optimize immunotherapy, understanding the tumor microenvironment …

Simple Summary In this review, we will analyze the main mutations predominant in the
various histotypes of salivary gland carcinomas, we will discover whether they behave as …

Salivary gland-type tumors of the lung are thought to originate from the submucosal exocrine
glands of the large airways. Due to their rare occurrence, reports of their study are limited to …

Background Salivary gland cancers (SGC) are rare and heterogeneous malignant tumors.
Advanced SGC lack established treatment options and show poor response to …

American Head and Neck Society Salivary Gland Section presented a multinational study of
the clinical behavior of low and intermediate salivary tumors. 1 In this large study, including …

For targeted delivery in the cancer model, this work intends to construct nanoparticles (NPs)
using folate (FA)-gemcitabine (GEM)-loaded polyvinylpyrrolidone (PVP)-gold (Au) …